Investor SentimentMeetings were highly positive and investor sentiment for the company continues to grow as it appears the worst is behind with infant formula, management is executing on its efficiency plans, there's significant FCF generation opportunity, and management is on track to deleverage.
Market SharePerrigo is making progress, with volume sales in each of the 6 weeks through 3/9 outpacing volume sales of the overall industry, highlighting share gains.
Regulatory EnvironmentThe FDA's Operation Stork Speed initiative to review and update infant formula standards could benefit Perrigo as the playing field is leveled among manufacturers.